EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2023 (TTM): $0.12

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is $0.13. In 2022 the company made an earnings per share (EPS) of $0.13 a decrease over its 2021 EPS that were of $0.16.

EPS history for Jiangsu Hengrui Medicine from 2002 to 2023

Annual EPS

Year	EPS	Change
2023 (TTM)	$0.12	-4.77%
2022	$0.13	-17.1%
2021	$0.16	-24.44%
2020	$0.21	20.3%
2019	$0.17	25.58%
2018	$0.14	27.55%
2017	$0.11	21.64%
2016	$0.08778	13.57%
2015	$0.07729	39.86%
2014	$0.05526	21.33%
2013	$0.04555	17.7%
2012	$0.03870	25.56%
2011	$0.03082	26.22%
2010	$0.02442	10.3%
2009	$0.02214	57.92%
2008	$0.01402	11.06%
2007	$0.01262	85.81%
2006	$0.006793	87.94%
2005	$0.003614	33.97%
2004	$0.002698	29.78%
2003	$0.002079	19.78%
2002	$0.001735

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions